Twenty five countries have reported outbreaks, including newly affected Sierra Leone where infections are surging.
Clinical trials of Jynneos have begun or will begin soon in infants and children 2 years old and younger, and in pregnant or breastfeeding women.
Amid promising signs, officials urged caution, noting that the outbreaks vary by clade, response measures, and social behaviors.
Vaccine supply shortage comes at a bad time, as African countries make headway with their outbreaks and have seen good uptake in affected populations.
WHO experts are seeing the same chikungunya warning signs that occurred two decades ago, when the virus swept across Indian Ocean countries.
About 6 in 10 presented accurate information on symptoms, preventive measures, and testing locations.
The ARTIC 2.0 project will expand use of a low-cost, real-time genome sequencing technique used to detect COVID-19 variants to conduct surveillance on a wider variety of pathogens.
Emergent BioSolutions has received a $56 million contract extension to supply the US government with doses of the ACAM2000 vaccine.
A larger proportion of patients with protracted cases were hospitalized than those with shorter infections (26% vs 5%).
The immune response in children aged 2 to 11 years was non-inferior to that observed in adults, and 2.5-times greater in children aged 2 to 5.
Whooping cough cases in Florida have risen by 81% this year compared with 2024.
The county announced the detection yesterday, and it involves an adult with no recent travel to mpox-endemic areas.
Rift Valley fever cases are rising in both people and animals in Senegal and Mauritania.
